SOPHiA GENETICS technology to aid research associated with hereditary cancers and disorders
Ankara Etlik City Hospital is Live on SOPHiA GENETICS Platform
read more
Press releases
NOMAD Genetics is Live on the SOPHiA GENETICS Platform
SOPHiA GENETICS technology aids NOMAD Genetics in the advancement of its cancer research...
SOPHiA GENETICS to Host Symposium at European Society of Human Genetics Annual Meeting
Leader in data-driven medicine will discuss progress in the adoption of exome and...
SOPHiA GENETICS Joins CancerX to Help Accelerate Cancer Research
As a leader in data-driven medicine, SOPHiA GENETICS lends its expertise to support White House Cancer Moonshot
SOPHiA GENETICS Announces Nomination of Lila Tretikov to Board of Directors
Microsoft’s Deputy Chief Technology Officer to be appointed at Annual Shareholders’ Meeting BOSTON...
SOPHiA GENETICS to Attend ASCO Annual Meeting
SOPHiA GENETICS leaders will talk onsite about the company’s cutting-edge SOPHiA DDM™ Platform
Institute of Oncology Ljubljana Leverages SOPHiA DDM ™ Platform for Cancer Research
SOPHiA DDMTM deep-learnings algorithm will help determine HRD status of tumors for Institute of Oncology Ljubljana researchers
Natural State Laboratories Chooses SOPHiA GENETICS to Help Launch their In-House Hereditary Cancer Testing
SOPHiA GENETICS technology will help increase cancer research abilities
Dasa Expands Its Capabilities with SOPHiA GENETICS
In just one year of using SOPHiA DDM™ HRD, Dasa reaches 2,000 samples analyzed BOSTON and...
SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2023
Strong growth momentum and efficient expense execution continues
SOPHiA GENETICS’ SOPHiA DDM™ HRD Solution is tapped by Unipath Specialty Laboratory Limited
SOPHiA GENETICS expands footprint in India as Unipath Specialty Laboratory Limited is now live on SOPHiA DDM™ HRD Solution
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2023 on May 9, 2023
BOSTON and GENEVA, Switzerland, April 25, 2023 (GLOBE NEWSWIRE) — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the first quarter of fiscal 2023 before U.S. markets open on Tuesday, May 9, 2023. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CEST.